Deals this week: Windancer, Bruin Biometrics, FusionHealth

7 December 2018 (Last Updated December 7th, 2018 11:03)

Windancer Technologies has signed an agreement for integrating its medical animation library with Visual Health Solutions' Cloud-based platform HarborMaster in an effort to improve patient care. 

Windancer Technologies has signed an agreement for integrating its medical animation library with Visual Health Solutions’ Cloud-based platform HarborMaster in an effort to improve patient care.

The companies will also generate personalised animation series to meet the requirement of clinicians and employers.

Both parties are healthcare technology companies based in the US.

Bruin Biometrics has received Small Business Innovation Research (SBIR) Phase II programme grant worth $1.4m from the National Institute of Arthritis and Musculoskeletal and Skin division of the National Institutes of Health (NIH).

The grant will assist the company in the development of investigational medical device OrthoSonos, which is intended to provide advanced care in the orthopaedics field.

Bruin Biometrics is a healthcare technology company based in the US.

FusionHealth has collaborated with the University of Michigan in a $45m deal to jointly conduct a clinical trial named Sleep SMART.

“The trial will evaluate if the diagnosis and treatment of obstructive sleep apnoea in patients can improve the chance of stroke recovery or help prevent another occurring.”

The trial will evaluate if the diagnosis and treatment of obstructive sleep apnoea in patients can improve the chance of stroke recovery or help prevent another one occurring.

Funding will be provided by NIH’s National Institute of Neurological Disorders and Stroke (NINDS). FusionHealth will provide equipment for CPAP and sleep apnoea testing to the clinical trial sites.

FusionHealth is a US-based healthcare technology company.

CIVCO Radiotherapy has signed a global supplier deal with POLL Medical for GrayDuck Stents worldwide.

CIVCO’s GrayDuck Stents are oral devices that have been customised for positioning and immobilisation of the tongue.

Both companies are healthcare technology providers based in the US.

Conformal Medical has received $9m in a series B funding round led by Catalyst Health Ventures.

Proceeds will be used for the development of its proprietary seal technology intended for the prevention of stroke in patients.

Conformal Medical is a medical device company headquartered in the US.